Evaluating the impact of school-based rebound therapy on chest health in children and young people with neurodisability and respiratory issues: a series of single case studies.

Saved in:
Bibliographic Details
Title: Evaluating the impact of school-based rebound therapy on chest health in children and young people with neurodisability and respiratory issues: a series of single case studies.
Authors: Knight Lozano, Rachel (AUTHOR), Shannon, Harriet (AUTHOR), Bell, Kayleigh (AUTHOR), Melluish, Julia (AUTHOR), Morris, Christopher (AUTHOR), Rapson, Rachel (AUTHOR), Marsden, Jonathan (AUTHOR)
Source: Disability & Rehabilitation. Dec2025, Vol. 47 Issue 24, p6384-6395. 12p.
Subjects: Treatment of respiratory diseases, Motor ability, Children with disabilities, Research funding, Interviewing, Questionnaires, Treatment effectiveness, Descriptive statistics, Cerebral palsy, Neurological disorders, Thematic analysis, Quality of life, Research methodology, Case studies, Adverse health care events, School health services, Physical activity, Adolescence, Children
Abstract: Purpose: To evaluate feasibility and impact of an individualised rebound therapy programme on chest health in children with complex neurodisability. Methods and materials: A single-case ABA design was conducted over 18 weeks with five children aged 5–15 years with complex neurodisability. Intervention involved twice weekly rebound therapy for six consecutive weeks in school. Summary outcomes included parent/carer-reported chest health, quality-of-life and clinician-observed motor ability. Serial weekly outcomes included chest health observations, usual care changes, adherence and adverse events. Parents completed a semi-structured interview after follow-up. Quantitative data were analysed descriptively and qualitative data were analysed using thematic analysis. Results: Within-case and across-case findings indicated improvement in motor ability following rebound therapy intervention. Additional trends of improvement were noted in parent/carer-reported chest health and quality-of-life, but these changes were not specific to the intervention phase. Improvements in motor ability, chest health and quality-of-life indicators were verified through qualitative interview data. Conclusion: Co-design successfully informed an inclusive, feasible intervention study for children with complex neurodisability. However, overall improvement in parent/carer-reported chest health, quality-of-life and observed motor ability were not limited to the intervention phase. Measurement tools lacked published thresholds to determine if changes were clinically significant. IMPLICATIONS FOR REHABILITATION: Rebound therapy is a feasible school-based intervention to promote rehabilitation through physical activity participation in children with complex neurodisability. Selected outcome measures require further psychometric testing to evaluate the impact of this rehabilitation approach effectively. Chest health education, monitoring and communication alongside rebound therapy may positively influence outcomes of rehabilitation, such as quality of life. Co-design and safety monitoring is necessary to address challenges of implementing rehabilitation research in children with complex neurodisability. [ABSTRACT FROM AUTHOR]
Copyright of Disability & Rehabilitation is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Description
Abstract:Purpose: To evaluate feasibility and impact of an individualised rebound therapy programme on chest health in children with complex neurodisability. Methods and materials: A single-case ABA design was conducted over 18 weeks with five children aged 5–15 years with complex neurodisability. Intervention involved twice weekly rebound therapy for six consecutive weeks in school. Summary outcomes included parent/carer-reported chest health, quality-of-life and clinician-observed motor ability. Serial weekly outcomes included chest health observations, usual care changes, adherence and adverse events. Parents completed a semi-structured interview after follow-up. Quantitative data were analysed descriptively and qualitative data were analysed using thematic analysis. Results: Within-case and across-case findings indicated improvement in motor ability following rebound therapy intervention. Additional trends of improvement were noted in parent/carer-reported chest health and quality-of-life, but these changes were not specific to the intervention phase. Improvements in motor ability, chest health and quality-of-life indicators were verified through qualitative interview data. Conclusion: Co-design successfully informed an inclusive, feasible intervention study for children with complex neurodisability. However, overall improvement in parent/carer-reported chest health, quality-of-life and observed motor ability were not limited to the intervention phase. Measurement tools lacked published thresholds to determine if changes were clinically significant. IMPLICATIONS FOR REHABILITATION: Rebound therapy is a feasible school-based intervention to promote rehabilitation through physical activity participation in children with complex neurodisability. Selected outcome measures require further psychometric testing to evaluate the impact of this rehabilitation approach effectively. Chest health education, monitoring and communication alongside rebound therapy may positively influence outcomes of rehabilitation, such as quality of life. Co-design and safety monitoring is necessary to address challenges of implementing rehabilitation research in children with complex neurodisability. [ABSTRACT FROM AUTHOR]
ISSN:09638288
DOI:10.1080/09638288.2025.2479080